Real‐world outcomes for 205 patients with chronic lymphocytic leukemia treated with ibrutinib-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Real‐world outcomes for 205 patients with chronic lymphocytic leukemia treated with ibrutinib

Published:2020-08-26 Issue:5 Volume:105 Page:646-654
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:Eur. J. Haematol.

Author:

Aarup Kathrine¹^ORCID,Rotbain Emelie Curovic¹²,Enggaard Lisbeth³,Pedersen Robert Schou⁴,Bergmann Olav Jonas⁵,Thomsen Rasmus Heje⁶,Frederiksen Mikael⁷,Frederiksen Henrik²^ORCID,Nielsen Tine²,Christiansen Ilse⁸,Andersen Michael Asger¹^ORCID,Niemann Carsten Utoft¹

Affiliation:

1. Department of Hematology, Rigshospitalet Copenhagen University Hospital Copenhagen Denmark

2. Department of Hematology Odense University Hospital Odense Denmark

3. Department of Hematology Herlev and Gentofte Hospital Herlev Denmark

4. Department of Hematology Hospitalsenheden Vest Holstebro Denmark

5. Department of Hematology Sygehus Lillebælt Vejle Denmark

6. Department of Hematology Zealand University Hospital Roskilde Denmark

7. Department of Hematology Sygehus Sønderjylland Aabenraa Denmark

8. Department of Hematology Aalborg University Hospital Aalborg Denmark

Funder

Danmarks Grundforskningsfond

AstraZeneca

Novo Nordisk Fonden

Publisher

Wiley

Subject

Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ejh.13499

Reference29 articles.

1. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015

2. Evolution of CLL treatment — from chemoimmunotherapy to targeted and individualized therapy

3. Bruton’s Tyrosine Kinase (BTK) Inhibitors in Clinical Trials

4. Ibrutinib versus Ofatumumab in Previously Treated Chronic Lymphoid Leukemia

5. Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. BTK inhibitors: moving the needle on the treatment of chronic lymphocytic leukemia;Expert Review of Hematology;2024-08-21

2. Real-World Outcome of Treatment with Single-Agent Ibrutinib in Italian Patients with Chronic Lymphocytic Leukemia: Final Results of the EVIdeNCE Study;Cancers;2024-03-20

3. Final results on effectiveness and safety of Ibrutinib in patients with chronic lymphocytic leukemia from the non-interventional FIRE study;Annals of Hematology;2024-03-06

4. Improved Innate Immune Function in Patients with Chronic Lymphocytic Leukemia Treated with Targeted Therapy in Clinical Trials;Clinical Cancer Research;2024-02-23

5. Identifying CLL patients at high risk of atrial fibrillation on treatment using machine learning;Leukemia & Lymphoma;2024-01-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3